Skip Navigation



NDT Advance Access published online on January 31, 2006
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfk086
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/4/854    most recent
gfk086v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Covic, A.
Right arrow Articles by Goldsmith, D. J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Covic, A.
Right arrow Articles by Goldsmith, D. J. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received August 18, 2005
Accepted December 30, 2005

Editorial Review

Is it time for spironolactone therapy in dialysis patients?

Adrian Covic 1 *, Paul Gusbeth-Tatomir 1, and David J. A. Goldsmith 2

1 Nephrology Clinic, Parhon University Hospital, Iasi, Romania
2 Renal Unit, Guy's Hospital, London, UK

* To whom correspondence should be addressed.
Adrian Covic, E-mail: acovic{at}xnet.ro



This article has no Abstract. Keywords: aldosterone; chronic kidney disease; end-stage renal disease; haemodialysis; hyperkalaemia; spironolactone.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 HypertensionHome page
K. Graf, T. Hucko, and P. Stawowy
Cardiac Benefits of Mineralocorticoid Receptor Inhibition in Renal Failure
Hypertension, August 1, 2008; 52(2): 209 - 210.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
L. Segall, A. Covic, and D. J. A. Goldsmith
Direct renin inhibitors: the dawn of a new era, or just a variation on a theme?
Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2435 - 2439.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. Lepenies and M. Quinkler
MR blockade in patients with chronic renal disease--not the more the merrier, but the earlier the better
Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3343 - 3344.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.